Alector's Series B Round

Alector raised a round of funding on March 10, 2014. Investors include Johnson & Johnson Innovation.

Alector is a neurology-focused startup that is pioneering the discovery and development of first-in-class, immuno-modulatory therapies for Alzheimer's disease and other neurodegenerative disorders. Th…

Articles about Alector's Series B Round: